Cover Image

Improving the efficacy for meropenem therapy requires a high probability of target attainment in critically ill infants and children

Probability of target attainment is the key factor influencing the outcome of meropenem therapy. The objective of the present study was to evaluate the relationship between the time in which the plasma free concentration of meropenem exceeds the minimum inhibitory concentration of pathogens (fT>M...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zeming Wang (Author), Jing Bi (Author), Dianping You (Author), Yu Tang (Author), Gang Liu (Author), Jinqian Yu (Author), Zhipeng Jin (Author), Tingting Jiang (Author), Xue Tian (Author), Hui Qi (Author), Lei Dong (Author), Lili Dong (Author), Qunqun Zhang (Author), Wei Zhao (Author), Adong Shen (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Meropenem for children with severe pneumonia: Protocol for a randomized controlled trial
by: Xue Tian, et al.
Published: (2022)

Evaluation of pharmacokinetic pharmacodynamic target attainment of meropenem in pediatric patients
by: Abdullah Alsultan, et al.
Published: (2024)

The Status of Psychological Issues Among Frontline Health Workers Confronting the Coronavirus Disease 2019 Pandemic
by: Zeming Hu, et al.
Published: (2020)

Biased computation of probability of target attainment for antimicrobial drugs
by: Pierre‐Louis Toutain, et al.
Published: (2023)

Characteristics of medicine use for children with asthma in China: a nationwide population-based study
by: Ping Wu, et al.
Published: (2022)

Decoding Multi-DoF Movements Using a CST-Based Force Generation Model With Single-DoF Training
by: Yang Xu, et al.
Published: (2024)

Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients
by: Ute Chiriac, et al.
Published: (2023)

Developmental Population Pharmacokinetics-Pharmacodynamics of Meropenem in Chinese Neonates and Young Infants: Dosing Recommendations for Late-Onset Sepsis
by: Yue-E Wu, et al.
Published: (2022)

Beta-Lactam Probability of Target Attainment Success: Cefepime as a Case Study
by: Daniel J. Selig, et al.
Published: (2023)

Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)
by: Yiwen Bao, et al.
Published: (2024)

Exogenous glutathione reverses meropenem resistance in carbapenem-resistant Klebsiella pneumoniae
by: Juan Yi, et al.
Published: (2023)

Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill Patients
by: Uwe Liebchen, et al.
Published: (2021)

Pharmacokinetic Analysis of Meropenem and Piperacillin in Critically-Ill Patients Requiring Continuous Ven-Venous Hemodiafiltration
by: Brandon Ferlas, et al.
Published: (2015)

Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection Treated Successfully With High-Dose Meropenem in a Preterm Neonate
by: Yue-E Wu, et al.
Published: (2020)

All Roads Lead to Rome: Enhancing the Probability of Target Attainment with Different Pharmacokinetic/Pharmacodynamic Modelling Approaches
by: Kashaf Khalid, et al.
Published: (2023)

Digital karyotyping reveals probable target genes at 7q21.3 locus in hepatocellular carcinoma
by: Wang Shengyue, et al.
Published: (2011)

The impact of vaccine hesitation on the intentions to get COVID-19 vaccines: The use of the health belief model and the theory of planned behavior model
by: Zeming Li, et al.
Published: (2022)

Bibliometric and visualization analysis of research trend in mental health problems of children and adolescents during the COVID-19 pandemic
by: Zeming Guo, et al.
Published: (2023)

The economic burden of medical treatment of children with asthma in China
by: Ping Wu, et al.
Published: (2020)

Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections
by: Pasquale Maria Berrino, et al.
Published: (2023)

Low‐dose versus high‐dose methylprednisolone for children with severe Mycoplasma pneumoniae pneumonia (MCMP): Study protocol for a randomized controlled trial
by: Baoping Xu, et al.
Published: (2018)

Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients
by: Femke de Velde, et al.
Published: (2021)

Nomogram for predicting early hypophosphatemia in term infants
by: Wan Tao, et al.
Published: (2024)

What Factors Predict the Adoption of Type 2 Diabetes Patients to Wearable Activity Trackers-Application of Diffusion of Innovation Theory
by: Ping Chen, et al.
Published: (2022)

Early Diagnosis of Mycoplasma pneumoniae in Children: Simultaneous Amplification and Testing (SAT) Is the Key
by: Jieqiong Li, et al.
Published: (2019)

Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021)

Development of 3D bioprinting: From printing methods to biomedical applications
by: Zeming Gu, et al.
Published: (2020)

PROBABLE FORECASTING IN THE COURSE OF INTERPRETING
by: Ye. B. Kagan, et al.
Published: (2017)

Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections
by: Shu-Ping Liu, et al.
Published: (2022)

Gender Disparities in the Association Between Educational Attainment and Cardiovascular-Kidney-Metabolic Syndrome: Cross-Sectional Study
by: Yi Ding, et al.
Published: (2024)

Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem
by: Maria Sanz Codina, et al.
Published: (2022)

Probability of Target Attainment of Tobramycin Treatment in Acute and Chronic <i>Pseudomonas aeruginosa</i> Lung Infection Based on Preclinical Population Pharmacokinetic Modeling
by: Bruna Bernar Dias, et al.
Published: (2022)

Meropenem pharmacokinetics in children: series of cases
by: Geisa Cristina da Silva Alves, et al.
Published: (2018)

Effects of lncRNA HOXA11-AS on Sevoflurane-Induced Neuronal Apoptosis and Inflammatory Responses by Regulating miR-98-5p/EphA4
by: Li Zhao, et al.
Published: (2023)

C/MIC > 4: A Potential Instrument to Predict the Efficacy of Meropenem
by: Yichang Zhao, et al.
Published: (2022)

Association between advanced lung cancer inflammation index and all-cause and cardiovascular mortality among stroke patients: NHANES, 1999-2018
by: Xiaokun Chen, et al.
Published: (2024)

Serum Cholinesterases, a Novel Marker of Clinical Activity in Inflammatory Bowel Disease: A Retrospective Case-Control Study
by: Xiaona Shao, et al.
Published: (2020)

CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT
by: I. I. Shteynberg, et al.
Published: (2015)

Population Pharmacokinetics of Meropenem in Critically Ill Korean Patients and Effects of Extracorporeal Membrane Oxygenation
by: Dong-Hwan Lee, et al.
Published: (2021)

Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected <i>Pseudomonas aeruginosa</i> Infection
by: Annabel Werumeus Buning, et al.
Published: (2021)